SCHEMBL7984273

SCHEMBL7984273

CCC(=O)Nc1ncn(Cc2ccc(-c3ccccc3C#N)cc2)c1C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.40
MME P08473 1/20 0.40
GRIA2 P42262 1/20 0.39
GRIA4 P48058 1/20 0.39
EGLN1 Q9GZT9 1/20 0.38
FFAR1 O14842 1/20 0.38
AKR1B1 P15121 1/20 0.38
ACHE P22303 1/20 0.38
DPP8 Q6V1X1 1/20 0.37
FGFR1 P11362 1/20 0.37
FGFR4 P22455 1/20 0.37
GSK3A P49840 1/20 0.37
GSK3B P49841 1/20 0.37
ADORA2A P29274 2/20 0.37
AGTR1 P30556 1/20 0.37
AGTR2 P50052 1/20 0.37
S1PR1 P21453 1/20 0.36
S1PR3 Q99500 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA1 Q13131 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988641 0.85 KMT2A (0.44) FGFR1FGFR4GSK3AGSK3BADORA2A
SCHEMBL7991565 0.82 TSHR (0.49) FGFR1FGFR4ALDH1A1CYP1A2CYP3A4
SCHEMBL7991782 0.82 PRKAG1 (0.43) PPARGMMEGRIA2GRIA4EGLN1
SCHEMBL7973987 0.79 FGFR1 (0.45) FGFR1FGFR4
SCHEMBL7987598 0.77 RIOK2 (0.41) FGFR1FGFR4GSK3AALDH1A1
SCHEMBL7984711 0.77 ABCC8 (0.44) FGFR1FGFR4
SCHEMBL7974223 0.77 RAB9A (0.46) ALDH1A1
SCHEMBL7986400 0.76 YTHDC1 (0.47) FGFR1FGFR4ALDH1A1HSD17B10
SCHEMBL7974162 0.75 KDM4E (0.52) EGLN1FGFR1FGFR4ALDH1A1
SCHEMBL7987555 0.74 GAA (0.47) GSK3AGSK3BPRKAA1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed